The use of clonidine in the management of autonomic overactivity in neuroleptic malignant syndrome

Clinical Autonomic Research

Volumn 10, Issue 4, 2000, Pages 193-196

  Gregorakos, Leonidas ^a   Thomaides, Thomas ^b,c   Stratouli, Stamatina ^a   Sakayanni, Ekaterini ^a  

^a Athens Trauma Hospital   (Greece)

^b Neurology Department   (Greece)

^c AGIA OLGA HOSPITAL   (Greece)

Author keywords

Autonomic nervous system; Clonidine; Neuroleptic malignant syndrome

Indexed keywords

ADRENALIN; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BROMOCRIPTINE; CLONIDINE; CREATINE KINASE; DANTROLENE; DIAZEPAM; NEUROLEPTIC AGENT; NORADRENALIN; PANCURONIUM;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; INTENSIVE CARE; MALE; NEUROLEPTIC MALIGNANT SYNDROME; SURVIVAL;

ADRENERGIC ALPHA-AGONISTS; ADULT; AGED; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CLONIDINE; CREATINE KINASE; EPINEPHRINE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME; NOREPINEPHRINE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034458306     PISSN: 09599851     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02291355     Document Type: Article

References (20)

1. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients
2. The neuroleptic malignant syndrome
3. Malignant hyperthermia susceptibility in neuroleptic malignant syndrome
4. Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome
5. Current concepts. Neuroleptic malignant syndrome
6. Sympathoadrenomedullary hyperactivity in the neuroleptic malignant syndrome: A case report
7. Central dopaminergic and noradrenergic receptor blockade in a patient with neuroleptic malignant syndrome
8. Effects of intracerebroventricular injection of clonidine on condition pressor and adrenergic responses in rats
9. The central hypotensive effect of clonidine studies on tetraplegic subjects
10. The clinical pharmacology of clonidine and related central antihypertensive agents
11. Neuroleptic malignant syndrome
12. Sympathoadrenomedullary activity in the neuroleptic malignant syndrome
13. Neuroleptic malignant syndrome. A study of CSF monoamine metabolism
14. Neuroleptic malignant syndrome
15. Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome
16. Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome
17. Pathogenesis of neuroleptic malignant syndrome
18. Declining frequency of neuroleptic malignant syndrome in a hospital population
19. Anti hypertensive agents and the drug therapy of hypertension
20. An account of the pharmacology of some antihypertensive drugs